Labcor Laboratories Ltd.

Total worldwide sales of heart valve disease treatment systems are set to expand at a compound annual growth rate (CAGR) of 10.9%, increasing from approximately $4,8 billion in 2016 to an estimated $8

The digital revolution and technological innovation are the key drivers that are accelerating diagnostic testing's shift away from the centralized laboratories with large high-capital equipment, towar